B-CELL LYMPHOMA STAGE II

B-CELL LYMPHOMA STAGE II was reported 21 times

B-CELL LYMPHOMA STAGE II is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Alkaloid [EPC] 1 0.0000
1 Aminosalicylate [EPC] 2 0.0000
2 Interferon beta [EPC] 3 0.0000
3 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
4 Purine Antimetabolite [EPC] 1 0.0000
5 Thiazide Diuretic [EPC] 2 0.0000
6 Antirheumatic Agent [EPC] 1 0.0000
7 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
8 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
9 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
10 Alkylating Drug [EPC] 1 0.0000
11 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
12 Proton Pump Inhibitor [EPC] 2 0.0000
13 Vitamin D [EPC] 1 0.0000
14 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
15 Corticosteroid [EPC] 4 0.0000
16 Vitamin B12 [EPC] 1 0.0000
17 Vitamin C [EPC] 1 0.0000
18 Insulin Analog [EPC] 1 0.0000
19 Atypical Antipsychotic [EPC] 1 0.0000
20 Loop Diuretic [EPC] 1 0.0000
21 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
22 Benzodiazepine [EPC] 1 0.0000